Medical technology company Sectra (STO: SECT B) announced on Monday a collaboration with Siemens Healthineers AG to enhance radiologists' diagnostic capabilities through seamless integration.
Radiologists can now access and post-process Siemens Healthineers' NAEOTOM Alpha class photon-counting CT images directly within Sectra's diagnostic application for radiology. This eliminates the need for users to switch applications or workstations for efficient image review.
NAEOTOM Alpha scanners generate contrast-rich images with high spatial resolution at a reduced radiation dose, benefiting cases requiring detailed visualization, such as brain and heart imaging. Lower radiation exposure is particularly advantageous for paediatric oncology patients requiring repeated scans.
Previously, full interactive utilization of spectral data from these images was limited to Siemens Healthineers' enterprise reading and reporting solution. Integration with Sectra's PACS now enables radiologists to perform spectral post-processing within their primary workflow. Combining Sectra's PACS capabilities with Siemens Healthineers' CT technology supports improved diagnostic accuracy and patient outcomes.
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis